NCT00713765View on ClinicalTrials.gov

Pharmacokinetic Interaction Between AZD3480 and Donepezil

PHASE1TerminatedINTERVENTIONAL

Enrollment

33

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Alzheimer's Disease

Interventions

DRUG

AZD3480

18 total doses of 40 mg, on days 1-18

DRUG

Donepezil

One single dose of mg on day 5

Trial Locations (1)

Unknown

Research Site, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY